331 related articles for article (PubMed ID: 12923401)
21. ACE (Angiotensin-Converting Enzyme) Inhibition Reverses Vasoconstriction and Impaired Dilation of Pial Collaterals in Chronic Hypertension.
Li Z; Lindner DP; Bishop NM; Cipolla MJ
Hypertension; 2020 Jul; 76(1):226-235. PubMed ID: 32418498
[TBL] [Abstract][Full Text] [Related]
22. Angiotensin-converting enzyme and angiotensin II receptor subtype 1 inhibitors restitute hypertensive internal anal sphincter in the spontaneously hypertensive rats.
De Godoy MA; Rattan S
J Pharmacol Exp Ther; 2006 Aug; 318(2):725-34. PubMed ID: 16648368
[TBL] [Abstract][Full Text] [Related]
23. Association of renal injury with nitric oxide deficiency in aged SHR: prevention by hypertension control with AT1 blockade.
Zhou XJ; Vaziri ND; Zhang J; Wang HW; Wang XQ
Kidney Int; 2002 Sep; 62(3):914-21. PubMed ID: 12164873
[TBL] [Abstract][Full Text] [Related]
24. Neuronal nitric oxide synthase is expressed in rat vascular smooth muscle cells: activation by angiotensin II in hypertension.
Boulanger CM; Heymes C; Benessiano J; Geske RS; Lévy BI; Vanhoutte PM
Circ Res; 1998 Dec 14-28; 83(12):1271-8. PubMed ID: 9851944
[TBL] [Abstract][Full Text] [Related]
25. Molecular mechanism of angiotensin II type I and type II receptors in cardiac hypertrophy of spontaneously hypertensive rats.
Makino N; Sugano M; Otsuka S; Hata T
Hypertension; 1997 Oct; 30(4):796-802. PubMed ID: 9336375
[TBL] [Abstract][Full Text] [Related]
26. Effects of antihypertensive drugs on capillary rarefaction in spontaneously hypertensive rats: intravital microscopy and histologic analysis.
Sabino B; Lessa MA; Nascimento AR; Rodrigues CA; Henriques Md; Garzoni LR; Levy BI; Tibiriçá E
J Cardiovasc Pharmacol; 2008 Apr; 51(4):402-9. PubMed ID: 18427284
[TBL] [Abstract][Full Text] [Related]
27. Hypothalamic hypertensive factor: an inhibitor of nitric oxide synthase activity.
Morris HR; Etienne AT; Panico M; Tippins JR; Alaghband-Zadeh J; Holland SM; Mehdizadeh S; de Belleroche J; Das I; Khan NS; de Wardener HE
Hypertension; 1997 Dec; 30(6):1493-8. PubMed ID: 9403572
[TBL] [Abstract][Full Text] [Related]
28. Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats.
De Gennaro Colonna V; Rigamonti A; Fioretti S; Bonomo S; Manfredi B; Ferrario P; Bianchi M; Berti F; Muller EE; Rossoni G
Eur J Pharmacol; 2005 Jun; 516(3):253-9. PubMed ID: 15963975
[TBL] [Abstract][Full Text] [Related]
29. Alterations of nitric oxide synthase expression with aging and hypertension in rats.
Chou TC; Yen MH; Li CY; Ding YA
Hypertension; 1998 Feb; 31(2):643-8. PubMed ID: 9461235
[TBL] [Abstract][Full Text] [Related]
30. Effects of angiotensin II type 1 receptor antagonist on smooth muscle cell phenotype in intramyocardial arteries from spontaneously hypertensive rats.
Kubo M; Umemoto S; Fujii K; Itoh S; Tanaka M; Kawahara S; Matsuzaki M
Hypertens Res; 2004 Sep; 27(9):685-93. PubMed ID: 15750263
[TBL] [Abstract][Full Text] [Related]
31. AT1 receptor antagonist combats oxidative stress and restores nitric oxide signaling in the SHR.
Welch WJ; Wilcox CS
Kidney Int; 2001 Apr; 59(4):1257-63. PubMed ID: 11260386
[TBL] [Abstract][Full Text] [Related]
32. Long-term inhibition of angiotensin prevents reduction of periarterial innervation of calcitonin gene-related peptide (CGRP)-containing nerves in spontaneously hypertensive rats.
Hobara N; Gessei-Tsutsumi N; Goda M; Takayama F; Akiyama S; Kurosaki Y; Kawasaki H
Hypertens Res; 2005 May; 28(5):465-74. PubMed ID: 16156511
[TBL] [Abstract][Full Text] [Related]
33. High-dose, not low-dose insulin increases the vasoconstrictor effect of norepinephrine in spontaneously hypertensive rats: effects of antihypertensive treatment.
Rizzoni D; Porteri E; Piccoli A; Castellano M; Pasini G; Guelfi D; Muiesan ML; Rosei EA
J Vasc Res; 1999; 36(5):393-403. PubMed ID: 10559680
[TBL] [Abstract][Full Text] [Related]
34. Is the balance between nitric oxide and superoxide altered in spontaneously hypertensive rats with endothelial dysfunction?
Zalba G; Beaumont FJ; San José G; Fortuño A; Fortuño MA; Díez J
Nephrol Dial Transplant; 2001; 16 Suppl 1():2-5. PubMed ID: 11369811
[TBL] [Abstract][Full Text] [Related]
35. Blockade of the renin-angiotensin system improves cerebral microcirculatory perfusion in diabetic hypertensive rats.
Estato V; Obadia N; Carvalho-Tavares J; Freitas FS; Reis P; Castro-Faria Neto H; Lessa MA; Tibiriçá E
Microvasc Res; 2013 May; 87():41-9. PubMed ID: 23466285
[TBL] [Abstract][Full Text] [Related]
36. Increased counteracting effect of eNOS and nNOS on an alpha1-adrenergic rise in total peripheral vascular resistance in spontaneous hypertensive rats.
Berg T
Cardiovasc Res; 2005 Sep; 67(4):736-44. PubMed ID: 15907821
[TBL] [Abstract][Full Text] [Related]
37. Two different approaches to restore renal nitric oxide and prevent hypertension in young spontaneously hypertensive rats: l-citrulline and nitrate.
Chien SJ; Lin KM; Kuo HC; Huang CF; Lin YJ; Huang LT; Tain YL
Transl Res; 2014 Jan; 163(1):43-52. PubMed ID: 24113064
[TBL] [Abstract][Full Text] [Related]
38. H+-ATPase activity on unilateral ureteral obstruction: interaction of endogenous nitric oxide and angiotensin II.
Valles PG; Manucha WA
Kidney Int; 2000 Oct; 58(4):1641-51. PubMed ID: 11012898
[TBL] [Abstract][Full Text] [Related]
39. Renal cortex remodeling in nitric oxide deficient rats treated with enalapril.
Barbuto N; Almeida JR; Pereira LM; Mandarim-de-Lacerda CA
J Cell Mol Med; 2004; 8(1):102-8. PubMed ID: 15090265
[TBL] [Abstract][Full Text] [Related]
40. Losartan and enalapril therapies enhance vasodilatation in the mesenteric artery of spontaneously hypertensive rats.
Kähönen M; Tolvanen JP; Kalliovalkama J; Wu X; Karjala K; Mäkynen H; Pörsti I
Eur J Pharmacol; 1999 Mar; 368(2-3):213-22. PubMed ID: 10193657
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
